Literature DB >> 2209118

Gemfibrozil interaction with warfarin sodium (coumadin)

S Ahmad.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2209118     DOI： 10.1378/chest.98.4.1041b

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  6 in total

1.  Effect of gemfibrozil on the pharmacokinetics and pharmacodynamics of racemic warfarin in healthy subjects.

Authors:  Jari J Lilja; Janne T Backman; Pertti J Neuvonen
Journal:  Br J Clin Pharmacol       Date:  2005-04       Impact factor: 4.335

Review 2.  Clinical pharmacokinetics of fibric acid derivatives (fibrates).

Authors:  D B Miller; J D Spence
Journal:  Clin Pharmacokinet       Date:  1998-02       Impact factor: 6.447

Review 3.  Antihyperlipidaemic agents. Drug interactions of clinical significance.

Authors:  J A Farmer; A M Gotto
Journal:  Drug Saf       Date:  1994-11       Impact factor: 5.606

Review 4.  Clinically important drug interactions with anticoagulants. An update.

Authors:  S Harder; P Thürmann
Journal:  Clin Pharmacokinet       Date:  1996-06       Impact factor: 6.447

Review 5.  Gemfibrozil. A reappraisal of its pharmacological properties and place in the management of dyslipidaemia.

Authors:  C M Spencer; L B Barradell
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546

6.  Fibrate/Statin initiation in warfarin users and gastrointestinal bleeding risk.

Authors:  Hedi Schelleman; Warren B Bilker; Colleen M Brensinger; Fei Wan; Yu-Xiao Yang; Sean Hennessy
Journal:  Am J Med       Date:  2010-02       Impact factor: 4.965
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.